Target intelligence / Profile preview

Pyruvate and energy metabolism enzymes

Molecular classification
Enzyme
01

Overview

Pyruvate and energy metabolism enzymes constitute a diverse group of catalytic proteins central to cellular respiration and bioenergetics. These enzymes, including pyruvate kinase (PK), the pyruvate dehydrogenase complex (PDC), and lactate dehydrogenase (LDH), manage the flux of carbon from glucose into the tricarboxylic acid (TCA) cycle or toward lactate production (UniProt: P08559, P14618). In oncology, these enzymes are often hijacked to support the Warburg effect, where cancer cells prioritize aerobic glycolysis over oxidative phosphorylation to sustain rapid growth and provide biosynthetic precursors (PubMed: 19762596). Therapeutic intervention involves either inhibiting these enzymes to disrupt the metabolic flexibility of tumor cells or activating them to correct genetic deficiencies, such as in pyruvate kinase deficiency (FDA: Mitapivat, 2022). Because these enzymes are fundamental to the survival of all cells, drug development in this area requires high selectivity to avoid systemic toxicity and metabolic crises in healthy tissues (StatPearls: Pyruvate Dehydrogenase Deficiency).

Other names
Pyruvate metabolism enzymesGlycolytic and TCA cycle enzymesEnergy metabolism pathway proteinsCentral carbon metabolism enzymes
02

Mechanism of action

Modulation of enzymatic activity within the pyruvate metabolism pathway, including allosteric activation of pyruvate kinase to restore ATP levels in erythrocytes, or inhibition of pyruvate dehydrogenase kinase (PDK) to reactivate the pyruvate dehydrogenase complex and promote mitochondrial oxidation in cancer cells.

03

Biological functions

GlycolysisGluconeogenesisCitric acid cycleATP productionCellular respirationMetabolic reprogramming
04

Disease associations

CancerMetabolic disorderDiabetes mellitusMitochondrial diseaseNeurodegenerative diseasePyruvate kinase deficiency
05

Safety considerations

Lactic acidosisHypoglycemiaPeripheral neuropathyMetabolic decompensationOff-target inhibition of systemic energy production
06

Interacting drugs

Mitapivat

6 more in the full profile.

07

Biomarkers

Lactate levelsPyruvate levelsGlucose-6-phosphateATP/ADP ratioFDG-PET glucose uptakeLDH isoenzyme levels

Beyond the preview

Go deeper on Pyruvate and energy metabolism enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyruvate and energy metabolism enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call